Endotoxin Note: BPC-157/TB-500 ("Wolverine Stack") is endotoxin-screened at the compound level. Full LAL test results available in the protocol COA.
Certificate of Analysis
Independent laboratory testing confirms purity and composition of this research peptide.
ENDO PASSED
99.90%
PURITY
B323197
BATCH
MAY 2026
DATE
GMPc Manufacturing
USA facility, ISO 9001:2015
Lyophilized for Stability
Intact for reconstitution and efficacy
99%+ HPLC Purity
Independently verified by accredited US Laboratory
Endotoxin-Screened
LAL tested, LPS-free, endotoxin report available
BPC-157/TB-500 "Wolverine Blend"
Wolverine Blend combines BPC-157 and TB-500 in one powerful dual-peptide research formulation. Designed for controlled laboratory use, it supports advanced preclinical investigation into cellular signaling, connective tissue organization, cytoskeletal regulation, and extracellular matrix dynamics.
$189.99
Dosage
Fast Free Shipping
Shipment Protection
5mg/5mg
Size
HPLC≥99%
Purity
Lyophilized Powder
Form
TECHNICAL SPECIFICATIONS
Protocol Information
Body Protection Compound-157
CAS Number
Molecular Formula
Molecular Weight
137525-51-0
C₆₂H₉₈N₁₆O₂₂
1419.56 g/mol
Thymosin Beta-4
CAS Number
Molecular Formula
Molecular Weight
77591-33-4
C₂₁₂H₃₅₀N₅₆O₇₈S
4963.44 g/mol
Stability Info
Lyophilized Powder
35° - 46° F
Reconstituted
35° - 46° F
KNOWLEDGE BASE
Lyophilized Powder
Lyophilized peptides are produced through a freeze-drying process that removes moisture to help maintain molecular stability during storage. Peptides may be supplied in either liquid or lyophilized powder form, depending on the formulation and intended use. Lyophilized presentations can offer superior structural preservation and higher potency by removing moisture that causes degradation.
BPC-157/TB-500 "Wolverine Stack"
The BPC-157 and TB-500 Blend combines two distinct, highly researched peptides into a single formulation for streamlined laboratory investigation. BPC-157 (Body Protection Compound-157) is a pentadecapeptide derived from human gastric juice protein, while TB-500 is a synthetic fraction of the protein thymosin beta-4. In research settings, this combination is frequently utilized to explore synergistic mechanisms of action regarding cellular migration, angiogenesis, and the maintenance of structural integrity in biological tissues.
Scientific literature extensively explores the individual and combined effects of these peptides. BPC-157 is investigated for its potential to modulate nitric oxide pathways and growth factor expression (such as VEGF and EGR-1), which are critical for vascular formation and wound healing models. Concurrently, TB-500 is studied for its role in actin sequestration, a process essential for cell motility and cytoskeletal restructuring. By analyzing these compounds together, researchers aim to understand how multi-pathway signaling might influence recovery processes in non-human experimental models involving muscle, tendon, and ligament tissues.
Peptide products offered through this platform are provided for informational and research purposes or are made available only pursuant to evaluation and authorization by a licensed healthcare provider, where applicable. These products are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. Use of any peptide product should be conducted under appropriate professional supervision. All content provided is for educational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional before beginning any new wellness or medical program.